You are here: Industry Insights > WuXi STA

News List

Hoth Therapeutics, WuXi STA Sign API and Drug Product Contracts contractpharma
December 10, 2021
WuXi STA to provide process development and manufacturing of the API and formulation of drug product for HT-KIT.
WuXi STA forms strategic partnership with Coherent Biopharma expresspharma
December 02, 2021
According to the agreement, WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated CMC services to accelerate its present and future drug candidates
Hoth Therapeutics, WuXi STA Ink API and Drug Product Pact ContractPharma
November 10, 2021
Hoth Therapeutics, Inc., a biopharmaceutical company, has entered into two contracts with STA Pharmaceutical, a subsidiary of WuXi AppTec (WuXi STA), for process development and manufacturing...
BMS Completes Sale of Couvet Site to WuXi STA contractpharma
August 05, 2021
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to WuXi STA, a subsidiary of WuXi AppTec.
WuXi STA completes acquisition of its first European facility cphi-online
August 05, 2021
The purchase of BMS's Couvet, Switzerland facility adds commercial-scale production capacity for capsule and tablet dosage forms
WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus contractpharma
June 30, 2021
The CDMO is bringing about 500 jobs to Middletown, site expected to open in 2024.
WuXi STA to build second US pharma manufacturing site at Middletown cphi-online
June 30, 2021
Facility is expected to come online in 2024 and will feature testing laboratories, manufacture of active pharmaceutical ingredients and manufacture and packaging of solid dosage pharmaceuticals and sterile products.
WuXi Biologics, WuXi STA Establish WuXi XDC JV contractpharma
May 17, 2021
WuXi Biologics and WuXi STA, a subsidiary of WuXi AppTec, established a joint venture company named WuXi XDC to provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs). Dr. Jimmy (Jincai) Li was ...
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services prnasia
May 14, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end contract development ...
WuXi STA to buy Swiss pharma manufacturing facility from Bristol Myers Squibb pharmaceutical-business-review
February 07, 2021
WuXi STA, a subsidiary of Chinese pharmaceutical company WuXi AppTec, has agreed to buy the Couvet, Switzerland-based manufacturing facility from Bristol Myers Squibb.

Previous page 1 2 Next page